|Articles|May 31, 2017
Chiltern Acquires Japanese CRO
Chiltern has acquired Integrated Development Associates (IDA), a Japanese CRO specializing in integrating Japan and Asia into global drug development.
Advertisement
Chiltern has acquired Integrated Development Associates (IDA), a Japanese CRO specializing in integrating Japan and Asia into global drug development. Under this acquisition, IDA will do business as a subsidiary of Chiltern and be renamed IDA, a Chiltern Company.
Read the full release
Newsletter
Stay current in clinical research with Applied Clinical Trials, providing expert insights, regulatory updates, and practical strategies for successful clinical trial design and execution.
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on Applied Clinical Trials Online
1
SCOPE Summit 2026: Where AI Is Making the Most Immediate Impact Across R&D
2
Meeting Halfway: Co-Developing Frameworks for Seamless FSO to FSP Transitions
3
SCOPE Summit 2026: ESG Shifts From Reporting Exercise to Vendor Readiness Test in Clinical Operations
4
Regulatory Uncertainty Emerges Across the Drug Development Lifecycle
5